ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,088 filers reported holding ASTRAZENECA PLC in Q2 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,226,558 | +36.1% | 208,059 | +18.3% | 0.02% | +30.8% |
| Q1 2024 | $11,919,076 | +20.5% | 175,927 | +19.8% | 0.01% | -27.8% |
| Q4 2023 | $9,891,676 | -13.4% | 146,870 | -12.9% | 0.02% | +20.0% |
| Q3 2023 | $11,421,968 | +2.6% | 168,665 | +8.5% | 0.02% | 0.0% |
| Q2 2023 | $11,127,392 | +18.5% | 155,476 | +14.9% | 0.02% | +7.1% |
| Q1 2023 | $9,391,417 | +5.8% | 135,304 | +3.3% | 0.01% | +7.7% |
| Q4 2022 | $8,880,671 | +42.8% | 130,983 | +15.5% | 0.01% | +18.2% |
| Q3 2022 | $6,218,000 | -6.9% | 113,389 | +12.2% | 0.01% | 0.0% |
| Q2 2022 | $6,680,000 | +0.0% | 101,098 | +0.4% | 0.01% | +10.0% |
| Q1 2022 | $6,677,000 | +71.5% | 100,647 | +50.6% | 0.01% | +66.7% |
| Q4 2021 | $3,893,000 | -5.1% | 66,838 | -2.2% | 0.01% | -14.3% |
| Q3 2021 | $4,104,000 | +20.8% | 68,328 | +20.4% | 0.01% | +16.7% |
| Q2 2021 | $3,398,000 | +3.4% | 56,740 | -14.1% | 0.01% | -14.3% |
| Q1 2021 | $3,286,000 | -3.1% | 66,082 | -2.6% | 0.01% | 0.0% |
| Q4 2020 | $3,392,000 | -4.6% | 67,863 | +4.6% | 0.01% | -22.2% |
| Q3 2020 | $3,555,000 | +12.0% | 64,881 | +8.1% | 0.01% | 0.0% |
| Q2 2020 | $3,173,000 | +44.2% | 59,999 | +21.7% | 0.01% | +12.5% |
| Q1 2020 | $2,201,000 | -2.0% | 49,288 | +9.4% | 0.01% | +14.3% |
| Q4 2019 | $2,246,000 | +21.9% | 45,038 | +8.9% | 0.01% | +16.7% |
| Q3 2019 | $1,843,000 | +4.4% | 41,348 | -3.3% | 0.01% | 0.0% |
| Q2 2019 | $1,765,000 | +2.3% | 42,755 | +0.2% | 0.01% | 0.0% |
| Q1 2019 | $1,725,000 | -0.5% | 42,676 | -6.5% | 0.01% | -14.3% |
| Q4 2018 | $1,733,000 | +6.1% | 45,639 | +10.6% | 0.01% | +16.7% |
| Q3 2018 | $1,634,000 | +28.9% | 41,282 | +14.3% | 0.01% | +20.0% |
| Q2 2018 | $1,268,000 | -0.9% | 36,124 | -1.3% | 0.01% | 0.0% |
| Q1 2018 | $1,280,000 | +1.3% | 36,590 | +0.5% | 0.01% | 0.0% |
| Q4 2017 | $1,264,000 | +2.0% | 36,414 | -0.4% | 0.01% | -16.7% |
| Q3 2017 | $1,239,000 | -18.4% | 36,562 | -17.9% | 0.01% | -25.0% |
| Q2 2017 | $1,518,000 | +7.6% | 44,531 | -1.7% | 0.01% | 0.0% |
| Q1 2017 | $1,411,000 | +25.1% | 45,321 | +9.8% | 0.01% | +14.3% |
| Q4 2016 | $1,128,000 | -6.2% | 41,281 | +12.8% | 0.01% | -12.5% |
| Q3 2016 | $1,202,000 | +41.1% | 36,581 | +29.6% | 0.01% | +33.3% |
| Q2 2016 | $852,000 | +129.6% | 28,228 | +114.5% | 0.01% | +100.0% |
| Q1 2016 | $371,000 | -18.1% | 13,159 | -8.1% | 0.00% | -25.0% |
| Q4 2015 | $453,000 | -1.3% | 14,326 | -6.9% | 0.00% | 0.0% |
| Q3 2015 | $459,000 | +26.8% | 15,388 | +191.1% | 0.00% | +33.3% |
| Q1 2015 | $362,000 | -6.5% | 5,287 | -29.2% | 0.00% | -25.0% |
| Q4 2014 | $387,000 | -0.5% | 7,468 | +2.0% | 0.00% | 0.0% |
| Q3 2014 | $389,000 | +10.2% | 7,321 | +54.0% | 0.00% | -20.0% |
| Q2 2014 | $353,000 | +18.5% | 4,754 | +3.5% | 0.01% | +25.0% |
| Q1 2014 | $298,000 | -15.3% | 4,595 | -22.4% | 0.00% | -33.3% |
| Q4 2013 | $352,000 | +54.4% | 5,924 | +35.1% | 0.01% | +20.0% |
| Q3 2013 | $228,000 | +132.7% | 4,386 | +111.2% | 0.01% | +150.0% |
| Q2 2013 | $98,000 | – | 2,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |